Bristol-Myers Squibb Co. (BMY) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Bristol-Myers Squibb Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

		Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
	Short-term borrowings
	Accounts payable
	Employee compensation and benefits
	Royalties
	Accrued research and development
	Restructuring, current
	Pension and postretirement benefits
	Accrued litigation
	Other
	Accrued expenses	%	%	%	%	%
	Deferred income
	Accrued rebates and returns
	U.S. and foreign income taxes payable
	Dividends payable
	Liabilities related to assets held for sale
	Current liabilities	%	%	%	%	%
	Pension, postretirement and postemployment liabilities
	Deferred income
	U.S. and foreign income taxes payable
	Other liabilities
	Long-term debt
	Non-current liabilities	%	%	%	%	%
	Total liabilities	%	%	%	%	%
	Preferred stock, $2 convertible series, par value $1 per share
	Common stock, par value of $0.10 per share
	Capital in excess of par value of stock
	Accumulated other comprehensive loss
	Retained earnings
	Cost of treasury stock
	Bristol-Myers Squibb Company shareholders’ equity	%	%	%	%	%
	Noncontrolling interest
	Total equity	%	%	%	%	%
	Total liabilities and equity	%	%	%	%	%

Top

May 19, 2012

Existing users sign in

Username:

Password:

Keep me signed in

Forgot your password?